4.7 Article

Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: A randomized, double-blind study in urban Asia

K. M. Fock et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2005)